Friday, June 19, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 351 of 1,261

  1. US 10980797

    Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors

    Corcept Therapeutics Incorporated · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  2. US 10980793

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  3. US 10980838

    Methods of treating ischemia

    Fate Therapeutics, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  4. US 10980788

    Therapy for treating malignancies

    Agios Pharmaceuticals, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  5. US 10980756

    Methods of treatment

    First Wave Bio, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  6. US 10980749

    Therapeutic preparation comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  7. US 10980767

    Estrogen receptor ligands, compositions and methods related thereto

    The Regents of the University of California · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  8. US 10980770

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  9. US 10980758

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    VISTAGEN THERAPUETICS, INC. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  10. US 10980744

    High density peptide polymers

    The Regents of the University of California · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  11. US 10982232

    Diterpene synthases and their use for production of diterpenes

    The Regents of the University of California · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  12. US 10975162

    Chimeric antigen receptor

    AUTOLUS LIMITED · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  13. US 10975153

    Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  14. US 10975142

    Endotrophin neutralization and use thereof

    The Board of Regents of the University of Texas System · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  15. US 10975124

    Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor

    The Board of Regents of the University of Oklahoma · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  16. US 10975138

    Correctly folded etanercept composition

    Coherus BioSciences, Inc. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  17. US 10975093

    Fused 1,4-diazepines as BET protein degraders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  18. US 10975061

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  19. US 10975059

    Small molecule BRD4 modulators for HIV epigenetic regulation

    The Board of Regents of the University of Texas System · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  20. US 10974235

    Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  21. US 10974077

    Low intensity focused ultrasound for treating cancer and metastasis

    Montefiore Medical Center · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  22. US 10975043

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  23. US 10973879

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  24. US 10973925

    Methods and compositions for theranostic nanoparticles

    Sanford Burnham Prebys Medical Discovery Institute at Lake Nona · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.